American Society of Hirudotherapy

Chronic Tonsillitis (Investigational Cervical Adjunct)

Highly investigational cervical adjunct for chronic tonsillitis; no clinical study found; tonsillectomy and antibiotics remain primary; cervical leech placement carries carotid-proximity risk.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 12, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for chronic tonsillitis. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use here is Tier C investigational.
What evidence exists?
Tier C (investigational). No clinical study of leech therapy for chronic tonsillitis was identified. Evidence-based first-line management is appropriate antibiotic therapy for confirmed bacterial episodes (penicillin for strep), management of comorbid conditions, and tonsillectomy for recurrent episodes that meet Paradise criteria (7+ episodes in 1 year, 5+ for 2 years, or 3+ for 3 years).
Main risks
  • Bleeding from each bite site for 6 to 10 hours after the leech detaches
  • Iron-deficiency anemia from cumulative blood loss across multiple sessions
  • Aeromonas hydrophila wound infection from leech gut bacteria (uncommon outside reconstructive surgery, but possible)
  • Allergic reaction to leech saliva (rare; ranges from local itching to anaphylaxis)
  • Small Y-shaped bite marks or skin colour changes at the bite sites, which usually fade over weeks to months
  • Local pain, bruising, swelling, or itching for 1 to 3 days after each session
  • Cervical placement risks — proximity to carotid artery, jugular vein, and major nerve trunks
  • Worsening of an active throat infection if applied during acute episode
Who should not consider this
  • Patients with active acute tonsillitis (need antibiotics, not leeches)
  • Patients meeting Paradise criteria for tonsillectomy (should be offered the proven surgical option)
  • Patients with suspected peritonsillar abscess (surgical drainage emergency)
  • Anyone on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran or heparin (daily aspirin alone is not a contraindication: tell your doctor, who starts with fewer leeches)
  • People with hemophilia or any other inherited bleeding disorder
  • Patients with anemia
  • People with an active infection at the planned application site
What to ask your clinician
  • Have I been evaluated by ENT and offered tonsillectomy if I meet Paradise criteria?
  • What is the proper antibiotic regimen for my confirmed bacterial episodes?
  • What is the published evidence base for leeches in chronic tonsillitis?
  • Where exactly on the neck will leeches be placed, and how is proximity to vessels and nerves managed?
  • What is the bleeding-control plan in the neck region?
  • How will success be measured — frequency of future episodes?
When to seek urgent care
  • Bleeding from a bite site that soaks through more than one dressing per hour
  • Bleeding that continues more than 24 hours after the leech detached
  • Spreading redness, warmth, swelling, pus, or red streaks around any bite site
  • Fever over 38.0 C / 100.4 F, chills, or feeling suddenly unwell after a session
  • Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
  • Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
  • Severe sore throat with high fever, drooling, muffled voice, or inability to swallow (possible peritonsillar abscess or epiglottitis)
  • Stridor, difficulty breathing, or rapid neck swelling
  • Bleeding from the mouth or throat

What this does NOT mean

  • It does not mean leech therapy is FDA-cleared for tonsillitis — the only FDA clearance is venous congestion in microsurgical reconstruction (K040187, June 2004).
  • It does not replace tonsillectomy for patients who meet Paradise criteria.
  • It does not replace appropriate antibiotic therapy during acute bacterial episodes.
  • It does not change tonsillar pathology or remove crypts that harbor recurrent infection.
  • It does not have controlled-trial evidence in this indication.

Clinical Profile

Category
ENT
ICD-10
J35.01, J35.03
Safety tier
High

Evidence Summary

Chronic tonsillitis is managed per AAO-HNS guidelines with antibiotics for acute exacerbations and tonsillectomy for recurrent disease meeting Paradise criteria. No clinical study of leech therapy for chronic tonsillitis, controlled or uncontrolled, was identified in PubMed, Europe PMC, Crossref, ClinicalTrials.gov or Russian-language searches; the only mentions found are a 1983 recommendation attributed to Bottenberg in the Baskova and Isakhanyan (2004) monograph and an indication list in a Russian popular book, neither with patient data. Its use is investigational and any rationale is mechanistic only, and bacterial pharyngotonsillitis, with tonsillar crypts harboring anaerobes, is not addressed by leech therapy. Critical safety: any leech placement would require avoiding the carotid artery, internal jugular vein, and major lymph node groups, and should be attempted by experienced operators only. Evidence is grade D.

What the books describe

Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.

  • Chronic tonsillitis (chronic inflammation of the tonsils) is named in the book by Baskova and Isakhanyan in only one list: they retell that Bottenberg (1983) recommends prescribing leeches to patients with acute and chronic inflammation of the tonsils and of the middle ear, with septic angina, and with acute otitis complicated by mastoiditis[B1].
  • Baskova and Isakhanyan give no descriptions of patients, no treatment regimen and no results for inflammation of the tonsils[B1].
  • Michalsen et al. do not write about tonsillitis (inflammation of the tonsils)[B3].
  • In the section on contraindications, Baskova and Isakhanyan advise refraining from hirudotherapy when the body temperature is high[B1].
  • Flecken and Michalsen (chapter 8) write that experience has shown that hirudotherapy during the acute stages of infectious diseases may lead to a feeling of weakness and impaired wound healing, and add that, according to the broader concepts of naturopathic medicine and humoral pathology, any treatment that extracts blood from patients with infections is generally considered counterproductive and is not recommended[B3].
  • Among the contraindications, Baskova and Isakhanyan, like Flecken and Michalsen in chapter 8 of the book by Michalsen et al., name hemophilia, anemia and concurrent use of anticoagulants (drugs that reduce blood clotting)[B1][B3].

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Active acute tonsillitis (treat with antibiotics first)
  • Tonsillectomy criteria met (surgical preferred)
  • Carotid disease or recent neck surgery
  • Suspected peritonsillar abscess (drain first)
  • Pediatric patient (no evidence in children)

Related Conditions

References

  • [B1]

    Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]

    Москва: Монолит(2004)https://search.rsl.ru/ru/record/01007959553

    Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.

  • [B3]

    Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy

    Stuttgart — New York: Thieme(2007)https://books.google.com/books?vid=ISBN9781588905635

    ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.

The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.